Anti-Human IgM antibody [EPR5539-65-4]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal IGHM antibody. Suitable for IP, WB and reacts with Human samples. Cited in 8 publications.
View Alternative Names
Immunoglobulin heavy constant mu, Ig mu chain C region, Ig mu chain C region BOT, Ig mu chain C region GAL, Ig mu chain C region OU, IGHM
- IP
Lab
Immunoprecipitation - Anti-Human IgM antibody [EPR5539-65-4] (AB134159)
Purified ab134159 at 1/20 dilution (1μg) immunoprecipitating Human IgM in Raji whole cell lysate.
Lane 1 (input) : Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate 10μg
Lane 2 (+) : ab134159 + Raji whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab134159 in Raji whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 75 kDa
All lanes:
Immunoprecipitation - Anti-Human IgM antibody [EPR5539-65-4] (ab134159)
Predicted band size: 49 kDa
false
- IP
Lab
Immunoprecipitation - Anti-Human IgM antibody [EPR5539-65-4] (AB134159)
purifiedab134159 at 1/50 dilution (2μg) immunoprecipitating Human IgM in Raji whole cell lysate.
Lane 1 (input) : Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate 10μg
Lane 2 (+) : ab134159 + Raji whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab134159 in Raji whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 75 kDa
All lanes:
Immunoprecipitation - Anti-Human IgM antibody [EPR5539-65-4] (ab134159)
Predicted band size: 49 kDa
false
- WB
Lab
Western blot - Anti-Human IgM antibody [EPR5539-65-4] (AB134159)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression or negative samples : MOLT-4, Jurkat (PMID : 24141767, PMID : 26121639).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.
All lanes:
Western blot - Anti-Human IgM antibody [EPR5539-65-4] (ab134159) at 1/1000 dilution
Lane 1:
Raji (human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Lane 2:
Daudi (human Burkitt's lymphoma lymphoblast) whole cell lysate at 20 µg
Lane 3:
MOLT-4 (human lymphoblastic leukemia T lymphoblast) whole cell lysate at 20 µg
Lane 4:
Jurkat (human T cell leukemia T lymphocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 75 kDa
false
- WB
Unknown
Western blot - Anti-Human IgM antibody [EPR5539-65-4] (AB134159)
Blocking Buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-Human IgM antibody [EPR5539-65-4] (ab134159) at 1/1000 dilution
All lanes:
Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 49 kDa
Observed band size: 75 kDa
false
Related conjugates and formulations (2)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Human IgM antibody [EPR5539-65-4]
-
Anti-Human IgM antibody [EPR5539-65-4] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:1506 PubMed39929829
2025
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 8:327 PubMed37661226
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of proteome research 21:274-288 PubMed34878788
2021
Applications
Unspecified application
Species
Unspecified reactive species
medRxiv : the preprint server for health sciences : PubMed34268518
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:641362 PubMed33868273
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of pediatric otorhinolaryngo 107:56-61 PubMed29501312
2018
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 37:385-393 PubMed29055600
2017
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cutaneous pathology 43:290-2 PubMed26469404
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com